ABSTRACT

Gynecologic oncology takes a fresh look at a critical aspect of cancer treatment planning. An international team of authors reviews the traditional prognostic and predictive factors such as tumor grade, histologic subtype, and grade and then goes a step further to review the growing number of molecular discoveries that have increasing clinical sign

part 1|2 pages

Clinical predictors of outcome in epithelial ovarian carcinoma

chapter 3|18 pages

Cell cycle and apoptotic markers

chapter 4|18 pages

TP53/p53 as a prognostic factor

part 10|2 pages

Rethinking traditional surgical–pathologic criteria for early

part 16|2 pages

Clinical–pathologic predictors in patients with cervical cancer